000 01472 a2200409 4500
005 20250517220130.0
264 0 _c20190403
008 201904s 0 0 eng d
022 _a1873-2968
024 7 _a10.1016/j.bcp.2018.05.015
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLowin, Torsten
245 0 0 _aSelective killing of proinflammatory synovial fibroblasts via activation of transient receptor potential ankyrin (TRPA1).
_h[electronic resource]
260 _bBiochemical pharmacology
_c08 2018
300 _a293-302 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aArthritis, Rheumatoid
_xmetabolism
650 0 4 _aCell Death
_xdrug effects
650 0 4 _aCells, Cultured
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aFemale
650 0 4 _aFibroblasts
_xdrug effects
650 0 4 _aHumans
650 0 4 _aInflammation Mediators
_xantagonists & inhibitors
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aSesquiterpenes
_xpharmacology
650 0 4 _aSynovial Membrane
_xcytology
650 0 4 _aTRPA1 Cation Channel
_xagonists
650 0 4 _aTumor Necrosis Factor-alpha
_xtoxicity
700 1 _aBleck, Janna
700 1 _aSchneider, Matthias
700 1 _aPongratz, Georg
773 0 _tBiochemical pharmacology
_gvol. 154
_gp. 293-302
856 4 0 _uhttps://doi.org/10.1016/j.bcp.2018.05.015
_zAvailable from publisher's website
999 _c28432528
_d28432528